1
|
Varga A, Nguyen MT, Pénzes K, Bátai B, Gyulavári P, Gurbi B, Murányi J, Csermely P, Csala M, Vántus T, Sőti C. Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration. Cells 2023; 12:cells12020212. [PMID: 36672148 PMCID: PMC9857065 DOI: 10.3390/cells12020212] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Revised: 12/12/2022] [Accepted: 12/28/2022] [Indexed: 01/06/2023] Open
Abstract
Prostate cancer metastasis is a significant cause of mortality in men. PKD3 facilitates tumor growth and metastasis, however, its regulation is largely unclear. The Hsp90 chaperone stabilizes an array of signaling client proteins, thus is an enabler of the malignant phenotype. Here, using different prostate cancer cell lines, we report that Hsp90 ensures PKD3 conformational stability and function to promote cancer cell migration. We found that pharmacological inhibition of either PKDs or Hsp90 dose-dependently abrogated the migration of DU145 and PC3 metastatic prostate cancer cells. Hsp90 inhibition by ganetespib caused a dose-dependent depletion of PKD2, PKD3, and Akt, which are all involved in metastasis formation. Proximity ligation assay and immunoprecipitation experiments demonstrated a physical interaction between Hsp90 and PKD3. Inhibition of the chaperone-client interaction induced misfolding and proteasomal degradation of PKD3. PKD3 siRNA combined with ganetespib treatment demonstrated a specific involvement of PKD3 in DU145 and PC3 cell migration, which was entirely dependent on Hsp90. Finally, ectopic expression of PKD3 enhanced migration of non-metastatic LNCaP cells in an Hsp90-dependent manner. Altogether, our findings identify PKD3 as an Hsp90 client and uncover a potential mechanism of Hsp90 in prostate cancer metastasis. The molecular interaction revealed here may regulate other biological and pathological functions.
Collapse
Affiliation(s)
- Attila Varga
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
- Correspondence: (A.V.); (C.S.)
| | - Minh Tu Nguyen
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
| | - Kinga Pénzes
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
- Institute of Medical Microbiology, Semmelweis University, 1089 Budapest, Hungary
| | - Bence Bátai
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
- HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary
| | - Pál Gyulavári
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
- IQVIA Hungary, 1117 Budapest, Hungary
| | - Bianka Gurbi
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
| | - József Murányi
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
| | - Péter Csermely
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
| | - Miklós Csala
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
| | - Tibor Vántus
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, 1094 Budapest, Hungary
| | - Csaba Sőti
- Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary
- Correspondence: (A.V.); (C.S.)
| |
Collapse
|
2
|
Varga A, Bátai B, Gyulavári P, Nguyen M, Sőti C, Vántus T. Heat shock protein 90 chaperones and protein kinase D3 regulates androgen-independent prostate cancer development. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz269.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Murányi J, Varga A, Gurbi B, Gyulavári P, Mező G, Vántus T. In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues. J Vis Exp 2017. [PMID: 28362408 DOI: 10.3791/55529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Abstract
GnRH analogues are effective targeting moieties and able to deliver anticancer agents selectively into malignant tumor cells which highly express GnRH receptors. However, the quantitative analysis of GnRH analogues' cellular uptake and the investigated cell types in GnRH-based drug delivery systems are currently limited. Previously introduced, selectively labeled fluorescent GnRH I, -II and -III derivatives provide great detectability, and they have suitable chemical properties for reproducible and robust experiments. We also found that the appropriate up-to-date methods with these labeled GnRH analogues could offer novel information about the GnRH-based drug delivery systems. This manuscript introduces some simple and fast experiments regarding the cellular uptake of [D-Lys6(FITC)]-GnRH-I, [D-Lys6(FITC)]-GnRH-II and [Lys8(FITC)]-GnRH-III on the EBC-1 (lung), the BxPC-3 (pancreas) and on the Detroit-562- (pharynx) malignant tumor cells. In parallel with these GnRH-FITC conjugates, the cell surface level of GnRH-I receptors was also examined on these cell lines before and after the GnRH treatment by confocal laser scanning microscopy. The cellular uptake of GnRH-FITC conjugates was quantified by fluorescence-activated cell sorting. In these experiments minor differences among GnRH analogues and major differences among cell types was observed. The significant differences among cell lines are correlated with their distinct level of cell surface GnRH-I receptors. The introduced experiments contain practical methods to visualize, quantify and compare the uptake efficiency of GnRH-FITC conjugates in a time- and concentration-dependent manner on various adherent cell cultures. These results could predict the drug targeting efficiency of GnRH conjugates on the given cell culture, and offer a good basis for further experiments in the examination of GnRH-based drug delivery systems.
Collapse
Affiliation(s)
- József Murányi
- MTA-SE Pathobiochemistry Research Group, Semmelweis University; Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University;
| | - Attila Varga
- MTA-SE Pathobiochemistry Research Group, Semmelweis University
| | - Bianka Gurbi
- MTA-SE Pathobiochemistry Research Group, Semmelweis University
| | - Pál Gyulavári
- MTA-SE Pathobiochemistry Research Group, Semmelweis University
| | - Gábor Mező
- MTA-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University
| | - Tibor Vántus
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University
| |
Collapse
|
4
|
Murányi J, Gyulavári P, Varga A, Bökönyi G, Tanai H, Vántus T, Pap D, Ludányi K, Mező G, Kéri G. Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, -II and -III analogues on various tumour cells. J Pept Sci 2017; 22:552-60. [PMID: 27443981 DOI: 10.1002/psc.2904] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2016] [Revised: 06/03/2016] [Accepted: 06/06/2016] [Indexed: 11/05/2022]
Abstract
Targeted tumour therapy is the focus of recent cancer research. Gonadotropin-releasing hormone (GnRH) analogues are able to deliver anticancer agents selectively into tumour cells, which highly express GnRH receptors. However, the effectiveness of different analogues as targeting moiety in drug delivery systems is rarely compared, and the investigated types of cancer are also limited. Therefore, we prepared selectively labelled, fluorescent derivatives of GnRH-I, -II and -III analogues, which were successfully used for drug targeting. In this manuscript, we investigated these analogues' solubility, stability and passive membrane permeability and compared their cellular uptake by various cancer cells. We found that these labelled GnRH conjugates provide great detectability, without undesired cytotoxicity and passive membrane permeability. The introduced experiments with these conjugates proved their reliable tracking, quantification and comparison. Cellular uptake efficiency was studied on human breast, colon, pancreas and prostate cancer cells (MCF-7, HT-29, BxPC-3, LNCaP) and on dog kidney cells (Madin-Darby canine kidney). Each of the three conjugates was taken up by GnRH-I receptor-expressing cells, but the different cells preferred different analogues. Furthermore, we demonstrated for the first time the high cell surface expression of GnRH-I receptors and the effective cellular uptake of GnRH analogues on human pharynx tumour (Detroit-562) cells. In summary, our presented results detail that the introduced conjugates could be innovative tools for the examination of the GnRH-based drug delivery systems on various cells and offer novel information about these peptides. Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- József Murányi
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary.,Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Pál Gyulavári
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Attila Varga
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Györgyi Bökönyi
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Henriette Tanai
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Tibor Vántus
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| | - Domonkos Pap
- 1st Department of Pediatrics, Semmelweis University, Bókay János St. 53-54, H1083, Budapest, Hungary
| | - Krisztina Ludányi
- Department of Pharmaceutics, Semmelweis University, Hőgyes Endre St. 7, H1092, Budapest, Hungary
| | - Gábor Mező
- MTA-ELTE Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Pázmány Péter sétány 1/A, H1518, Budapest, Hungary
| | - György Kéri
- MTA-SE Pathobiochemistry Research Group, Tűzoltó St. 37-47, H1094, Budapest, Hungary.,Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Tűzoltó St. 37-47, H1094, Budapest, Hungary
| |
Collapse
|
5
|
Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T. Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro. PLoS One 2015; 10:e0144792. [PMID: 26672602 PMCID: PMC4681468 DOI: 10.1371/journal.pone.0144792] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
6
|
Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T. Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro. PLoS One 2015; 10:e0124234. [PMID: 25874616 PMCID: PMC4396990 DOI: 10.1371/journal.pone.0124234] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2014] [Accepted: 02/27/2015] [Indexed: 12/18/2022] Open
Abstract
Emerging evidence suggests that the vascular endothelial growth factor receptor 2 (VEGFR2) and protein kinase D1 (PKD1) signaling axis plays a critical role in normal and pathological angiogenesis and inflammation related processes. Despite all efforts, the currently available therapeutic interventions are limited. Prior studies have also proved that a multiple target inhibitor can be more efficient compared to a single target one. Therefore, development of novel inflammatory pathway-specific inhibitors would be of great value. To test this possibility, we screened our molecular library using recombinant kinase assays and identified the previously described compound VCC251801 with strong inhibitory effect on both VEGFR2 and PKD1. We further analyzed the effect of VCC251801 in the endothelium-derived EA.hy926 cell line and in different inflammatory cell types. In EA.hy926 cells, VCC251801 potently inhibited the intracellular activation and signaling of VEGFR2 and PKD1 which inhibition eventually resulted in diminished cell proliferation. In this model, our compound was also an efficient inhibitor of in vitro angiogenesis by interfering with endothelial cell migration and tube formation processes. Our results from functional assays in inflammatory cellular models such as neutrophils and mast cells suggested an anti-inflammatory effect of VCC251801. The neutrophil study showed that VCC251801 specifically blocked the immobilized immune-complex and the adhesion dependent TNF-α -fibrinogen stimulated neutrophil activation. Furthermore, similar results were found in mast cell degranulation assay where VCC251801 caused significant reduction of mast cell response. In summary, we described a novel function of a multiple kinase inhibitor which strongly inhibits the VEGFR2-PKD1 signaling and might be a novel inhibitor of pathological inflammatory pathways.
Collapse
Affiliation(s)
- Attila Varga
- Pathobiochemistry Research Group, Hungarian Academy of Sciences—Semmelweis University, Budapest, Hungary
| | - Pál Gyulavári
- Pathobiochemistry Research Group, Hungarian Academy of Sciences—Semmelweis University, Budapest, Hungary
| | | | - Krisztina Futosi
- Department of Physiology, Semmelweis University, Budapest, Hungary
| | - Tamás Németh
- Department of Physiology, Semmelweis University, Budapest, Hungary
| | - Laura Simon-Szabó
- Department of Immunology, Eötvös Loránd University, Budapest, Hungary
| | - Krisztina Kerekes
- Department of Immunology, Eötvös Loránd University, Budapest, Hungary
| | | | - Diána Brauswetter
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
| | - Márton Kokas
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
| | - Gábor Borbély
- Pathobiochemistry Research Group, Hungarian Academy of Sciences—Semmelweis University, Budapest, Hungary
| | - Anna Erdei
- Department of Immunology, Eötvös Loránd University, Budapest, Hungary
| | - Attila Mócsai
- Department of Physiology, Semmelweis University, Budapest, Hungary
| | - György Kéri
- Pathobiochemistry Research Group, Hungarian Academy of Sciences—Semmelweis University, Budapest, Hungary
- Vichem Chemie Research Ltd., Budapest, Hungary
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
| | - Tibor Vántus
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
- * E-mail:
| |
Collapse
|
7
|
Csete D, Győri D, Vántus T, Kéri G, Szántai-Kis C, Mócsai A. A4.18 The effects of SRC-family kinase inhibitors on osteoclast development in vitro. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-207259.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Szokol B, Gyulavári P, Kurkó I, Baska F, Szántai-Kis C, Greff Z, Őrfi Z, Peták I, Pénzes K, Torka R, Ullrich A, Őrfi L, Vántus T, Kéri G. Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors. ACS Med Chem Lett 2014; 5:298-303. [PMID: 24900830 DOI: 10.1021/ml4003309] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2013] [Accepted: 01/30/2014] [Indexed: 01/23/2023] Open
Abstract
Activating mutations in the epidermal growth factor receptor (EGFR) have been identified in a subset of non-small cell lung cancer (NSCLC), which is one of the leading cancer types worldwide. Application of EGFR tyrosine kinase inhibitors leads to acquired resistance by secondary EGFR mutations or by amplification of the hepatocyte growth factor receptor (c-Met) gene. Although several EGFR and c-Met inhibitors have been reported, potent dual EGFR/c-Met inhibitors, which can overcome this latter resistance mechanism, have hitherto not been published and have not reached clinical trials. In the present study we have identified dual EGFR/c-Met inhibitors and designed novel N-[4-(quinolin-4-yloxy)-phenyl]-biarylsulfonamide derivatives, which inhibit the c-Met receptor and both the wild-type and the activating mutant EGFR kinases in nanomolar range. We have demonstrated by Western blot analysis that compound 10 inhibits EGFR and c-Met phosphorylation at cellular level and effectively inhibits viability of the NSCLC cell lines.
Collapse
Affiliation(s)
| | - Pál Gyulavári
- MTA-SE
Pathobiochemistry Research Group, Department of Medical Chemistry, Semmelweis University, 1085 Budapest, Hungary
| | - Ibolya Kurkó
- Vichem Chemie Research Ltd., 1022 Budapest, Hungary
| | - Ferenc Baska
- Vichem Chemie Research Ltd., 1022 Budapest, Hungary
- Rational
Drug-Design Laboratory Cooperation Research Centre, Semmelweis University, 1085 Budapest, Hungary
| | | | - Zoltán Greff
- Vichem Chemie Research Ltd., 1022 Budapest, Hungary
| | - Zoltán Őrfi
- Rational
Drug-Design Laboratory Cooperation Research Centre, Semmelweis University, 1085 Budapest, Hungary
- Max Planck Institute of Biochemistry, Munich 82152, Germany
| | - István Peták
- MTA-SE
Pathobiochemistry Research Group, Department of Medical Chemistry, Semmelweis University, 1085 Budapest, Hungary
- KPS Medical Biotechnology and Healthcare Services Ltd., 1022 Budapest, Hungary
| | - Kinga Pénzes
- Max Planck Institute of Biochemistry, Munich 82152, Germany
| | - Robert Torka
- Max Planck Institute of Biochemistry, Munich 82152, Germany
| | - Axel Ullrich
- Max Planck Institute of Biochemistry, Munich 82152, Germany
| | - László Őrfi
- Vichem Chemie Research Ltd., 1022 Budapest, Hungary
- Department
of Pharmaceutical Chemistry, Semmelweis University, 1085 Budapest, Hungary
| | - Tibor Vántus
- MTA-SE
Pathobiochemistry Research Group, Department of Medical Chemistry, Semmelweis University, 1085 Budapest, Hungary
| | - György Kéri
- Vichem Chemie Research Ltd., 1022 Budapest, Hungary
- MTA-SE
Pathobiochemistry Research Group, Department of Medical Chemistry, Semmelweis University, 1085 Budapest, Hungary
- Rational
Drug-Design Laboratory Cooperation Research Centre, Semmelweis University, 1085 Budapest, Hungary
| |
Collapse
|
9
|
Borbély G, Huszár M, Varga A, Futosi K, Mócsai A, Orfi L, Idei M, Mandl J, Kéri G, Vántus T. Optimization of important early ADME(T) parameters of NADPH oxidase-4 inhibitor molecules. Med Chem 2012; 8:174-81. [PMID: 22385185 DOI: 10.2174/157340612800493674] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2011] [Revised: 07/20/2011] [Accepted: 10/27/2011] [Indexed: 11/22/2022]
Abstract
Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo- and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability.
Collapse
Affiliation(s)
- Gábor Borbély
- Pathobiochemistry Research Group of Hungarian Academy of Sciences, Department of Medical Chemistry, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Futosi K, Németh T, Pick R, Vántus T, Walzog B, Mócsai A. Dasatinib inhibits proinflammatory functions of mature human neutrophils. Blood 2012; 119:4981-91. [PMID: 22411867 PMCID: PMC3367900 DOI: 10.1182/blood-2011-07-369041] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2011] [Accepted: 03/02/2012] [Indexed: 12/25/2022] Open
Abstract
Dasatinib is a tyrosine kinase inhibitor used to treat imatinib-resistant chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. At present, little is known about how dasatinib influences nonmalignant cells. In the present study, we tested the effect of dasatinib on functional responses of normal mature human neutrophils. Dasatinib completely blocked integrin- and Fc-receptor-mediated neutrophil functions, with the lowest IC(50) values below 10nM under serum-free conditions. Dasatinib caused a partial inhibition of neutrophil responses triggered by G-protein-coupled receptors and had a moderate effect on neutrophil responses triggered by microbial compounds. Whereas dasatinib inhibited neutrophil chemotaxis under static conditions in 2 dimensions, it did not affect migration under flow conditions or in 3-dimensional environments. Dasatinib did not have any major effect on phagocytosis or killing of bacteria by neutrophils. Adhesion of human neutrophils in the presence of whole serum was significantly inhibited by 50-100nM dasatinib, which corresponds to the reported serum concentrations in dasatinib-treated patients. Finally, ex vivo adhesion of mouse peripheral blood neutrophils was strongly reduced after oral administration of 5 mg/kg of dasatinib. Those results suggest that dasatinib treatment may affect the proinflammatory functions of mature neutrophils and raise the possibility that dasatinib-related compounds may provide clinical benefit in neutrophil-mediated inflammatory diseases.
Collapse
Affiliation(s)
- Krisztina Futosi
- Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary
| | | | | | | | | | | |
Collapse
|
11
|
Borbély G, Szabadkai I, Horváth Z, Markó P, Varga Z, Breza N, Baska F, Vántus T, Huszár M, Geiszt M, Hunyady L, Buday L, Orfi L, Kéri G. Small-molecule inhibitors of NADPH oxidase 4. J Med Chem 2010; 53:6758-62. [PMID: 20731357 DOI: 10.1021/jm1004368] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
NOX enzymes are the major contributors in many oxidative damage related diseases. Unfortunately, at present no specific NOX inhibitor is available. Here, we describe the discovery and development of novel NOX4 inhibitors. Compound libraries were tested in a cell-based assay as a primary screen, monitoring H2O2 production. Twenty-four compounds inhibited Nox4 activity with low-micromolar IC(50) values of which three were selected for further drug development.
Collapse
|
12
|
Huszár M, Varga A, Horváth A, Loránd T, Agócs A, Idei M, Mandl J, Vántus T, Kéri G. Comparative characterization of experimental and calculated lipophilicity and anti-tumour activity of isochromanone derivatives. Curr Med Chem 2010; 17:321-33. [PMID: 20015044 DOI: 10.2174/092986710790192703] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2009] [Accepted: 01/19/2009] [Indexed: 11/22/2022]
Abstract
Compound lipophilicity connected to ADME(T)(a) has great importance in drug development and it has to be evaluated by the generally used drug developmental process. In addition to the importance of lipophilicity in ADMET, recently it has been reported that lipophilicity of small molecules correlates with their antiproliferative activity because of certain specific hydrophobic and lipophilic interactions. Due to the complexity of ADME(T) parameters an efficient and fast method is needed to characterize the many promising candidate lead molecules as a preselection in order not to be rejected from the latter phase of drug development. In the present paper we provide an overview of the importance of lipophilicity of drug candidates for biological action and for ADME(T) and describe a novel approach for drug-likeness characterization of a molecular library using correlation study between lipophilicity and biological activity. Lipophilicity and molecular characteristics have been measured, predicted and optimized for a diverse library from which the best members have been selected to describe their biological, chemical and drug-likeness properties. Molecules were selected from the family of alpha,beta-unsaturated ketones and thorough HPLC characterization for lipophilicity and morphological, antiproliferative and flow cytometric studies were carried out on them. Based on the results 17 member isochromanone library including E and Z geometric isomers were selected for further characterization. In this focused library linear correlation has been found between the calculated and measured lipophilicity and significant parabolic correlation was found between the antiproliferative effect and lipophilicity. Using our efficient and fast method, from a diverse library, we identified an outstandingly effective inhibitor of A431 tumour cell growth via a PARP(a) cleavage dependent apoptosis. In summary the optimized HPLC analyses of lipophilicity combined with the cell-culture assay, introduced above, resulted in the determination of an optimal lipophilicity range. This optimized lipophilicity range should be used in designing novel antiproliferative compounds.
Collapse
Affiliation(s)
- M Huszár
- The Pathobiochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
d’Angelo I, Garcia-Fuentes M, Parajó Y, Welle A, Vántus T, Horváth A, Bökönyi G, Kéri G, Alonso MJ. Nanoparticles Based on PLGA:Poloxamer Blends for the Delivery of Proangiogenic Growth Factors. Mol Pharm 2010; 7:1724-33. [DOI: 10.1021/mp1001262] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Ivana d’Angelo
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Marcos Garcia-Fuentes
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Yolanda Parajó
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Alexander Welle
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Tibor Vántus
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Anikó Horváth
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Györgyi Bökönyi
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - György Kéri
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| | - Maria José Alonso
- Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain, Department of Pharmaceutical and Toxicological Chemistry, University Federico II, Naples, Italy, Institute for Biological Interfaces, Forschungszentrum Karlsruhe, Karlsruhe, Germany, and Pathobiochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary
| |
Collapse
|
14
|
Donkó A, Orient A, Szabó PT, Németh G, Vántus T, Kéri G, Orfi L, Hunyady L, Buday L, Geiszt M. Detection of hydrogen peroxide by lactoperoxidase-mediated dityrosine formation. Free Radic Res 2009; 43:440-5. [PMID: 19340621 DOI: 10.1080/10715760902859069] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The aim of this work was to study the dityrosine-forming activity of lactoperoxidase (LPO) and its potential application for measuring hydrogen peroxide (H2O2). It was observed that LPO was able to form dityrosine at low H2O2 concentrations. Since dityrosine concentration could be measured in a simple fluorimetric reaction, this activity of the enzyme was utilized for the measurement of H2O2 production in different systems. These experiments successfully measured the activity of NADPH oxidase 4 (Nox4) by this method. It was concluded that LPO-mediated dityrosine formation offers a simple way for H2O2 measurement.
Collapse
Affiliation(s)
- Agnes Donkó
- Department of Physiology, Semmelweis University, Faculty of Medicine, Budapest, Hungary
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Miyazaki A, Tsuda Y, Fukushima S, Yokoi T, Vántus T, Bökönyi G, Szabó E, Horváth A, Kéri G, Okada Y. Synthesis of Somatostatin Analogues Containing C-Terminal Adamantane and Their Antiproliferative Properties. J Med Chem 2008; 51:5121-4. [DOI: 10.1021/jm701599w] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Anna Miyazaki
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Yuko Tsuda
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Shoji Fukushima
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Toshio Yokoi
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Tibor Vántus
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Gyöngyi Bökönyi
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Edit Szabó
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Anikó Horváth
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - György Kéri
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| | - Yoshio Okada
- Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry, Kobe Gakuin University, Nishi-ku, Kobe, 651-2180, Japan, and Pathobiochemistry Research Group of Hungarian Academy of Science and Semmelweis University, H-1088 Budapest, Hungary
| |
Collapse
|
16
|
Vántus T, Vertommen D, Saelens X, Rykx A, De Kimpe L, Vancauwenbergh S, Mikhalap S, Waelkens E, Kéri G, Seufferlein T, Vandenabeele P, Rider MH, Vandenheede JR, Van Lint J. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing. Cell Signal 2004; 16:703-9. [PMID: 15093611 DOI: 10.1016/j.cellsig.2003.11.009] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2003] [Accepted: 11/25/2003] [Indexed: 11/21/2022]
Abstract
Recent studies have demonstrated the importance of protein kinase D (PKD) in cell proliferation and apoptosis. Here, we report that in vitro cleavage of recombinant PKD1 by caspase-3 generates two alternative active PKD fragments. N-terminal sequencing of these fragments revealed two distinct caspase-3 cleavage sites located between the acidic and pleckstrin homology (PH) domains of PKD1. Moreover, we present experimental evidence that PKD1 is an in vitro substrate for both initiator and effector caspases. During doxorubicin-induced apoptosis, a zVAD-sensitive caspase induces cleavage of PKD1 at two sites, generating fragments with the same molecular masses as those determined in vitro. The in vivo caspase-dependent generation of the PKD1 fragments correlates with PKD1 kinase activation. Our results indicate that doxorubicin-mediated apoptosis induces activation of PKD1 through a novel mechanism involving the caspase-mediated proteolysis.
Collapse
Affiliation(s)
- Tibor Vántus
- Biochemistry, Faculty of Medicine, Katholieke Universiteit Leuven, Belgium
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Vántus T, Kéri G, Krivickiene Z, Valius M, Steták A, Keppens S, Csermely P, Bauer PI, Bökönyi G, Declercq W, Vandenabeele P, Merlevede W, Vandenheede JR. The somatostatin analogue TT-232 induces apoptosis in A431 cells: sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinases. Cell Signal 2001; 13:717-25. [PMID: 11602182 DOI: 10.1016/s0898-6568(01)00194-2] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
TT-232 is a somatostatin analogue containing a five-residue ring structure. The present report describes TT-232-induced signalling events in A431 cells, where a 4-h preincubation with the peptide irreversibly induced a cell death program, which involves DNA-laddering and the appearance of shrunken nuclei, but is unrelated to somatostatin signalling. Early intracellular signals of TT-232 include a transient two-fold activation of the extracellular signal-regulated kinase (ERK2) and a strong and sustained activation of the stress-activated protein kinases c-Jun NH(2)-terminal kinase (JNK)/SAPK and p38MAPK. Blocking the signalling to ERK or p38MAPK activation had no effect on the TT-232-induced cell killing. At the commitment time for inducing cell death, TT-232 decreased EGFR-tyrosine phosphorylation and prevented epidermial growth factor (EGF)-induced events like cRaf-1 and ERK2 activation. Signalling to ERK activation by FCS, phorbol 12-myristate 13-acetate (PMA) and platelet-derived growth factor (PDGF) was similarly blocked. Our data suggest that TT-232 triggers an apoptotic type of cell death, concomitant with a strong activation of JNK and a blockade of cellular ERK2 activation pathways.
Collapse
Affiliation(s)
- T Vántus
- Peptide Biochemistry Research Group, Department of Medical Biochemistry, Budapest H-1088, Hungary
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Steták A, Lankenau A, Vántus T, Csermely P, Ullrich A, Kéri G. The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src. Biochem Biophys Res Commun 2001; 285:483-8. [PMID: 11444868 DOI: 10.1006/bbrc.2001.5199] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The heptapeptide TT-232 is structurally related to the hypothalamic hormone somatostatin and shows promise as an anticancer drug because of its tumor-specific cytotoxic effects. Apart from the ability to induce apoptosis, the synthetic peptide can trigger an alternative pathway that leads to cell cycle arrest in certain tumor cell systems. We found that pulse treatment with TT-232 blocks the cell cycle G(1)/S transition irreversibly in A431 cells. Investigation of the TT-232 signaling pathway yielded results similar to those reported for somatostatin although its affinity to the somatostatin receptor 1 is significantly reduced. We show that functional protein kinase C (PKC) delta as well as c-Src are necessary mediators of the TT-232 cytostatic effect and we propose a signaling pathway that leads to cell cycle arrest.
Collapse
Affiliation(s)
- A Steták
- Peptide Chemistry Research Group, Semmelweis University, Budapest, H-1088 Hungary.
| | | | | | | | | | | |
Collapse
|
19
|
Mócsai A, Jakus Z, Vántus T, Berton G, Lowell CA, Ligeti E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 2000; 164:4321-31. [PMID: 10754332 DOI: 10.4049/jimmunol.164.8.4321] [Citation(s) in RCA: 242] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The aim of the present study was to investigate the role of tyrosine phosphorylation pathways in fMLP-induced exocytosis of the different secretory compartments (primary and secondary granules, as well as secretory vesicles) of neutrophils. Genistein, a broad specificity tyrosine kinase inhibitor, blocked the exocytosis of primary and secondary granules, but had only a marginal effect on the release of secretory vesicles. Genistein also inhibited the phosphorylation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinases (MAPK), raising the possibility that inhibition of ERK and/or p38 MAPK might be responsible for the effect of the drug on the degranulation response. Indeed, SB203580, an inhibitor of p38 MAPK, decreased the release of primary and secondary granules, but not that of secretory vesicles. However, blocking the ERK pathway with PD98059 had no effect on any of the exocytic responses tested. PP1, an inhibitor of Src family kinases, also attenuated the release of primary and secondary granules, and neutrophils from mice deficient in the Src family kinases Hck, Fgr, and Lyn were also defective in secondary granule release. Furthermore, activation of p38 MAPK was blocked by both PP1 and the hck-/-fgr-/-lyn-/- mutation. Taken together, our data indicate that fMLP-induced degranulation of primary and secondary granules of neutrophils is mediated by p38 MAPK activated via Src family tyrosine kinases. Although piceatannol, a reportedly selective inhibitor of Syk, also prevented degranulation and activation of p38 MAPK, no fMLP-induced phosphorylation of Syk could be observed, raising doubts about the specificity of the inhibitor.
Collapse
Affiliation(s)
- A Mócsai
- Department of Physiology, Semmelweis University of Medicine, Budapest, Hungary.
| | | | | | | | | | | |
Collapse
|
20
|
Assefa Z, Valius M, Vántus T, Agostinis P, Merlevede W, Vandenheede JR. JNK/SAPK activation by platelet-derived growth factor in A431 cells requires both the phospholipase C-gamma and the phosphatidylinositol 3-kinase signaling pathways of the receptor. Biochem Biophys Res Commun 1999; 261:641-5. [PMID: 10441479 DOI: 10.1006/bbrc.1999.1090] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Wild-type or mutant betaPDGF receptors were introduced into A431 cells that lack endogenous PDGF receptors. PDGF stimulates JNK1 activity in a dose- and time-dependent manner in cells expressing the wild-type receptor. A receptor mutant lacking all the binding sites for SHP-2, GAP, PI3K, and PLC-gamma fails to activate JNK1. Receptor mutants with no binding site for either SHP-2 or GAP can fully activate JNK1 but those which do not bind either PI3K or PLC-gamma are unable to induce JNK1 activation. PDGF-dependent JNK1 activation was reduced upon cell pretreatment with wortmannin or GF109203X and is completely abrogated by chronic PMA stimulation. Altogether, these results indicate that PDGF activates JNK1 through a pathway that involves both PI3K and PLC-gamma and subsequent activation of protein kinase C.
Collapse
Affiliation(s)
- Z Assefa
- Faculty of Medicine, KU Leuven, Herestraat 49, Leuven, B-3000, Belgium
| | | | | | | | | | | |
Collapse
|
21
|
Kéri G, Erchegyi J, Horváth A, Mezõ I, Idei M, Vántus T, Balogh A, Vadász Z, Bökönyi G, Seprõdi J, Teplán I, Csuka O, Tejeda M, Gaál D, Szegedi Z, Szende B, Roze C, Kalthoff H, Ullrich A. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci U S A 1996; 93:12513-8. [PMID: 8901613 PMCID: PMC38023 DOI: 10.1073/pnas.93.22.12513] [Citation(s) in RCA: 71] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
We report a series of new in vitro and in vivo data proving the selective antitumor activity of our somatostatin structural derivative, TT-232. In vitro, it inhibited the proliferation of 20 different human tumor cell lines in the range of 50-95% and induced a very strong apoptosis. In vivo TT-232 was effective on transplanted animal tumors (Colon 26, B16 melanoma, and S180 sarcoma) and on human tumor xenografts. Treatment of MDA-MB-231 human breast cancer xenografted in mice with low submaximal doses of TT-232 [0.25 and 0.5 mg/kg of body weight (b.w.)] caused an average 80% decrease in the tumor volume resulting in 30% tumor-free animals surviving for longer than 200 days. Treatment of prostate tumor (PC-3) xenografted animals with 20 mg/kg of b.w. of TT-232 for 3 weeks resulted in 60% decrease in tumor volume and 100% survival even after 60 days, while 80% of nontreated animals perished. We have demonstrated that TT-232 did not bind to the membrane preparation of rat pituitary and cortex and had no antisecretory activity. TT-232 was not toxic at a dose of 120 mg/kg of b.w. in mice. Long-term incubation (24 h) of tumor cells with TT-232 caused significant inhibition of tyrosine kinases in good correlation with the apoptosis-inducing effect. The level of p53 or KU86 did not change following TT-232 treatment, suggesting a p53-independent apoptotic effect. Preincubation of human breast cancer cells (MDA-MB-453) with TT-232 for 2 h decreased the growth factor receptor autophosphorylation. All of these data suggest that TT-232 is a promising and selective antitumor agent.
Collapse
Affiliation(s)
- G Kéri
- Joint Research Organization, Hungarian Academy of Sciences, Budapest, Hungary
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
Aperiodic self-similar oscillations of trypsin activity were shown by experiments conducted in the presence of Mn2+ ion at pH 8.2 and -10 degrees C in frozen (cryo-oscillations) and at 0 degrees and 25 degrees C under unstirred conditions, respectively. The solution of trypsin obtained by trypsinogen activation and of 0.1 M MnCl2 was distributed into samples or kept in batches at the experimental temperature and sampled. At given time intervals the samples were tested for tryptic activity. In experiments at -10 degrees C the samples were frozen at the initiating of the series. The irregular shapes of activity curves as well as the trajectory of a next-amplitude plot is discussed as a result of a sensitive coupling between the chemical/conformational and diffusional controls of the enzyme activity in the far-from-equilibrium heterogeneous system. These indicate that the self-similar character of the trypsin activity oscillations can be considered on a phenomenological level.
Collapse
Affiliation(s)
- T Vajda
- Department of Organic Chemistry, Eötvös University, Budapest, Hungary
| | | | | |
Collapse
|
23
|
Kéri G, Mezô I, Vadász Z, Horváth A, Idei M, Vántus T, Balogh A, Bökönyi G, Bajor T, Teplán I. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Pept Res 1993; 6:281-8. [PMID: 7903057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
A series of new somatostatin analogs were synthesized in order to study the relative importance of specific substitutions in relation to selectivity between their endocrine and antitumor effects. Substitutions were carried out in all positions, except for Lys in position 5. Peptides were tested for their ability to inhibit in vitro and in vivo GH release, proliferation of the MCF 7 breast carcinoma cell line and tyrosine kinase activity in the HT 29 human colon carcinoma cell line. Selective biological activity was achieved in GH release and antitumor activity by the different amino acid substitutions. One of the analogs, with a five-residue ring (D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2, TT-232), was unique. It had no GH release inhibitory activity, but did have strong tyrosine kinase inhibitory and antiproliferative effects.
Collapse
Affiliation(s)
- G Kéri
- Semmelweis University Medical School, Hungary
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Kéri G, Mezö I, Horváth A, Vadász Z, Balogh A, Idei M, Vántus T, Teplán I, Mák M, Horváth J. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity. Biochem Biophys Res Commun 1993; 191:681-7. [PMID: 8096383 DOI: 10.1006/bbrc.1993.1271] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A series of new somatostatin analogs have been developed and tested for antitumor activity. Some analogs strongly inhibited tyrosine kinase activity of human colon tumor cells and this activity correlated well with their antiproliferative effect, but did not correlate with GH release inhibition. The best analogs strongly inhibited the metastasis formation in the Lewis lung metastasis model in mice. On the basis of these in vitro and in vivo data we were able to select one analog with strong tyrosine kinase inhibitory and antitumor activity, without inhibiting growth hormone release.
Collapse
Affiliation(s)
- G Kéri
- 1st Inst. Biochemistry, Joint. Res. Org. of Hung. Acad. Sci. and Semmelweis Med. Univ., Budapest
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Kéri G, Balogh A, Horváth A, Mezö I, Vadász Z, Bökönyi G, Bajor T, Vántus T, Teplán I, Horváth J. Novel antitumor peptide hormones and their effect on signal transduction. J Steroid Biochem Mol Biol 1992; 43:105-10. [PMID: 1356011 DOI: 10.1016/0960-0760(92)90193-m] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitumor activity on DMBA induced mammary carcinomas in rats without blocking ovarian functions. The direct effect of Folligen and Buserelin has been compared on the human breast cancer cell line MDA-MB-231. Folligen was found to be more effective in inhibiting cell proliferation and significant differences were found in the signal transduction pathways activated by these analogs. Our novel Somatostatin analogs were screened for tyrosine kinase inhibition and for antiproliferative effect on human colon tumor cells and for growth hormone (GH) release inhibition in vitro and in vivo. The analog TT-2-50 was significantly more active inhibiting GH release in superfused rat pituitary cells and in vivo than native Somatostatin and it strongly inhibited tyrosine kinase and proliferation while it stimulated protein kinase C activity.
Collapse
Affiliation(s)
- G Kéri
- Semmelweis University Medical School, 1st Institute of Biochemistry, Budapest, Hungary
| | | | | | | | | | | | | | | | | | | |
Collapse
|